| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $25K | +3.7% | — |
| R&D Expense | $10K | -33.3% | -85.5% |
| SG&A Expense | $58K | -62.0% | -6.6% |
| Operating Income | -$153K | +48.2% | +38.1% |
| Interest Expense | $435K | +1.3% | +266.2% |
| Net Income | -$599K | -191.6% | -110.5% |
| EPS (Basic) | $0.00 | — | -100.0% |
| EPS (Diluted) | $0.00 | — | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $16K | — | — |
| Accounts Receivable | $27K | -60.2% | — |
| Current Assets | $49K | +1086.9% | +2696.5% |
| Total Assets | $191K | +26.7% | +100.0% |
| Total Liabilities | $4.3M | +10.1% | -62.5% |
| Stockholders' Equity | -$4.1M | -9.4% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$330K | — | — |
| Investing Cash Flow | $12K | — | — |
| Financing Cash Flow | $328K | — | — |
| +63.8% |